Results 91 to 100 of about 15,116 (248)

Abdominal Aortic Dissection in a Patient With Autosomal Dominant Polycystic Kidney Disease After Starting Peritoneal Dialysis

open access: yesUrology Case Reports, 2014
Autosomal dominant polycystic kidney disease (ADPKD), one of the most common genetic disorders, is caused by mutations in the PKD1 or PKD2 gene.
Yingying He   +6 more
doaj   +1 more source

A Case Study of Liver After Kidney Transplantation: Addressing Polycystic Diseases With Tailored Surgical and Postoperative Approaches

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Polycystic liver disease is a hereditary disease, which is characterized by the presence of multiple cysts within the liver. In this case, we report a patient with multiple cysts in the kidneys and liver, who underwent kidney transplantation in 2019 and then liver transplantation 4 years later.
Chengjun Sun   +4 more
wiley   +1 more source

Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models

open access: yesScientific Reports, 2017
Autosomal polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by the development of numerous fluid-filled cysts in both kidneys.
Yu mi Woo   +14 more
semanticscholar   +1 more source

A Rare Diagnosis of Caroli Syndrome in a Young Patient

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Caroli syndrome is a rare but serious congenital disorder associated with portal hypertension and polycystic kidney disease. Early diagnosis via imaging, particularly MRCP, is crucial to prevent life‐threatening complications such as cholangitis and biliary cirrhosis.
Elaheh Karimzadeh‐Soureshjani   +4 more
wiley   +1 more source

Copeptin: a marker for ADPKD progression? [PDF]

open access: yesNephrology Dialysis Transplantation, 2012
Autosomal dominant polycystic kidney disease (ADPKD) accounts for ∼5–10% of patients with end-stage renal disease (ESRD) [1]. Mutations in the PKD1 and PKD2 gene, encoding polycystin-1 (PC-1) and -2 (PC-2), account for ∼85 and 15% of diseases, respectively.
Christoph Wanner, Wiebke Fenske
openaire   +3 more sources

Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca 2+ -permeable nonselective cation channel [PDF]

open access: green, 2000
Silvia González‐Perrett   +9 more
openalex   +2 more sources

Contemporary Perspectives on Chronic Renal Disorders

open access: yesChronic Diseases and Translational Medicine, Volume 11, Issue 2, Page 89-104, June 2025.
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok   +5 more
wiley   +1 more source

Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD

open access: yesJournal of Biomedical Sciences, 2016
BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder and is a common genetic cause of chronic renal failure in children and adults.
Gnanasambandan Ramanathan   +3 more
semanticscholar   +1 more source

Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease

open access: yesKidney & Blood Pressure Research, 2019
Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD).
Silvia Lai   +7 more
doaj   +1 more source

Operative and nonoperative management of acute cholecystitis in patients on chronic kidney replacement therapy

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, Volume 32, Issue 6, Page 465-475, June 2025.
Assessing the outcomes of acute cholecystitis in patients on chronic kidney replacement therapy, Palamuthusingam and colleagues found that cholecystectomy did not improve 30‐day survival compared with nonoperative management. Although surgery resulted in higher rates of early morbidity, it was associated with significantly better survival at 12 months.
Dharmenaan Palamuthusingam   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy